<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38914852</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1433-8491</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Jun</Month><Day>25</Day></PubDate></JournalIssue><Title>European archives of psychiatry and clinical neuroscience</Title><ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation></Journal><ArticleTitle>Headache severity in patients with post COVID-19 condition: a case-control study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-024-01850-8</ELocationID><Abstract><AbstractText>Post COVID-19 conditions (PCC) present with a wide range of symptoms. Headache is one of the most frequently reported neurological symptoms by patients with PCC. We aimed to assess the prevalence of headache in patients with PCC who attended the Post-COVID<sup>LMU</sup> outpatient department at LMU University Hospital in Munich. We hypothesized that headaches occur more frequently in patients with PCC than in the control group. Patients answered a questionnaire containing sociodemographic characteristics, their current symptoms, and prior psychiatric and somatic diagnoses, the WHO Quality of Life assessment (WHOQOL-BREF), 9-item Patient Health Questionnaire (PHQ-9), and the Fatigue Severity Scale (FSS). 188 PCC patients were included in this study and compared to a control group of patients with a history of COVID-19 or a different infectious disease - but no consecutive post-infectious condition (n<sub>c</sub>=27). 115 (61%) of our PCC patients were female. The median age was 41 years. 60 (32%, p&#x2009;=&#x2009;0.001) had a pre-existing psychiatric diagnosis. PCC was associated with worse outcomes in all four domains of the WHOQOL-BREF (p&#x2009;&lt;&#x2009;0.001), high levels of fatigue (FSS; p&#x2009;&lt;&#x2009;0.001), and a higher likeliness for symptoms of depression (PHQ-9; p&#x2009;&lt;&#x2009;0.001). We were able to confirm that psychiatric disorders are more frequently associated with headaches in PCC patients. Headache should be assessed and treated in the context of PCC not only by neurologists but by multi-professional teams and regarding all PCC symptoms.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rueb</LastName><ForeName>Mike</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2057-383X</Identifier><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nu&#xdf;baumstra&#xdf;e 7, 80336, Munich, Germany. mike.rueb@med.uni-muenchen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pettenkofer School of Public Health, Munich, Germany. mike.rueb@med.uni-muenchen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute for Medical Information Processing, Biometry and Epidemiology, LMU University Hospital, LMU Munich, Munich, Germany. mike.rueb@med.uni-muenchen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for International Health (CIH LMU), LMU University Hospital, LMU Munich, Munich, Germany. mike.rueb@med.uni-muenchen.de.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Medical Education, LMU University Hospital, LMU Munich, Munich, Germany. mike.rueb@med.uni-muenchen.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruzicka</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2451-1070</Identifier><AffiliationInfo><Affiliation>Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fonseca</LastName><ForeName>Gerardo Jesus Ibarra</ForeName><Initials>GJI</Initials><AffiliationInfo><Affiliation>Department of Medicine IV, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Valdinoci</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nu&#xdf;baumstra&#xdf;e 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benesch</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pernpruner</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>von Baum</LastName><ForeName>Max</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Remi</LastName><ForeName>Jan</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1527-9350</Identifier><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jebrini</LastName><ForeName>Tarek</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Psychiatry and Psychotherapy, LMU University Hospital, LMU Munich, Nu&#xdf;baumstra&#xdf;e 7, 80336, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sch&#xf6;berl</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Straube</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Stubbe</LastName><ForeName>Hans Christian</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0002-7873-996X</Identifier><AffiliationInfo><Affiliation>Department of Medicine II, LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>German Centre for Infection Research (DZIF), Partner Site Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Adorjan</LastName><ForeName>Kristina</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7501-9556</Identifier><AffiliationInfo><Affiliation>Center for International Health (CIH LMU), LMU University Hospital, LMU Munich, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatric Phenomics and Genomics, LMU University Hospital, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Hospital of Psychiatry and Psychotherapy, University of Bern, Bern, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA><NlmUniqueID>9103030</NlmUniqueID><ISSNLinking>0940-1334</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Headache</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Post COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>25</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>24</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38914852</ArticleId><ArticleId IdType="doi">10.1007/s00406-024-01850-8</ArticleId><ArticleId IdType="pii">10.1007/s00406-024-01850-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Augustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health &#x2013; Europe. https://doi.org/10.1016/j.lanepe.2021.100122</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100122</ArticleId><ArticleId IdType="pubmed">34308410</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T et al (2021) Attributes and predictors of long COVID. Nat Med 27:626&#x2013;631</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId><ArticleId IdType="pmc">7611399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27:601&#x2013;615</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId><ArticleId IdType="pmc">8893149</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallek M, Adorjan K, Behrends U, Ertl G, Suttorp N, Lehmann C (2023) Post-COVID syndrome. Dtsch Arztebl Int 120:48&#x2013;55</Citation><ArticleIdList><ArticleId IdType="pubmed">36633452</ArticleId><ArticleId IdType="pmc">10060997</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg M, Maralakunte M, Garg S et al (2021) The Conundrum of Long-COVID-19: a narrative review. Int J Gen Med 14:2491&#x2013;2506</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S316708</ArticleId><ArticleId IdType="pubmed">34163217</ArticleId><ArticleId IdType="pmc">8214209</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik P, Patel K, Pinto C, Jaiswal R, Tirupathi R, Pillai S, Patel U (2022) Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)&#x2014;A systematic review and meta-analysis. J Med Virol 94:253&#x2013;262</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27309</ArticleId><ArticleId IdType="pubmed">34463956</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition . Accessed 6 Jul 2023</Citation></Reference><Reference><Citation>(2020) Healthcare Workers. In: Centers for Disease Control and Prevention. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html . Accessed 10 Jul 2023</Citation></Reference><Reference><Citation>Stefanou M-I, Palaiodimou L, Bakola E et al (2022) Neurological manifestations of long-COVID syndrome: a narrative review. Ther Adv Chronic Dis 13:20406223221076890</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20406223221076890</ArticleId><ArticleId IdType="pubmed">35198136</ArticleId><ArticleId IdType="pmc">8859684</ArticleId></ArticleIdList></Reference><Reference><Citation>Severo Bem Junior L, Do Rego Aquino PL, Nunes Rabelo N, Do Rego Aquino MA, Veiga Silva AC, Ferreira Valenca Mota RDC, Rocha Cirne De Azevedo Filho H (2020) SARS-CoV-2 and Nervous System - neurological manifestations in patients with COVID-19: a systematic review. J Neurol Res 10:113&#x2013;121</Citation><ArticleIdList><ArticleId IdType="doi">10.14740/jnr602</ArticleId><ArticleId IdType="pubmed">33984094</ArticleId><ArticleId IdType="pmc">8040459</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F, Gemelli Against, COVID-19 Post-Acute Care Study Group (2020) Persistent symptoms in patients after Acute COVID-19. JAMA 324:603&#x2013;605</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId><ArticleId IdType="pmc">7349096</ArticleId></ArticleIdList></Reference><Reference><Citation>Beghi E, Giussani G, Westenberg E et al (2022) Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions. J Neurol 269:2265&#x2013;2274</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10848-4</ArticleId><ArticleId IdType="pubmed">34674005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C, Bentivegna E, Cho S-J et al (2022) Long COVID headache. J Headache Pain 23:93</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId><ArticleId IdType="pmc">9340759</ArticleId></ArticleIdList></Reference><Reference><Citation>(2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1&#x2013;211</Citation></Reference><Reference><Citation>Chhabra N, Grill MF, Singh RBH (2022) Post-COVID headache: a Literature Review. Curr Pain Headache Rep 26:835&#x2013;842</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11916-022-01086-y</ArticleId><ArticleId IdType="pubmed">36197571</ArticleId><ArticleId IdType="pmc">9533267</ArticleId></ArticleIdList></Reference><Reference><Citation>Premraj L, Kannapadi NV, Briggs J, Seal SM, Battaglini D, Fanning J, Suen J, Robba C, Fraser J, Cho S-M (2022) Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: a meta-analysis. J Neurol Sci 434:120162</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2022.120162</ArticleId><ArticleId IdType="pubmed">35121209</ArticleId><ArticleId IdType="pmc">8798975</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv 2021.01.27.21250617</Citation></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Navarro-Santana M, G&#xf3;mez-Mayordomo V, Cuadrado ML, Garc&#xed;a-Azor&#xed;n D, Arendt-Nielsen L, Plaza-Manzano G (2021) Headache as an acute and post-COVID-19 symptom in COVID-19 survivors: a meta-analysis of the current literature. Eur J Neurol 28:3820&#x2013;3825</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15040</ArticleId><ArticleId IdType="pubmed">34327787</ArticleId><ArticleId IdType="pmc">8444899</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues AN, Dias ARN, Paranhos ACM, Silva CC, Bastos T da, de Brito R, da Silva BB, de Sousa NM, de Quaresma E, Falc&#xe3;o JAS (2023) LFM Headache in long COVID as disabling condition: A clinical approach. Front Neurol 14:1149294</Citation></Reference><Reference><Citation>Franke C, Berlit P, Pr&#xfc;ss H (2022) Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology. Neurol Res Pract 4:28</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-022-00191-y</ArticleId><ArticleId IdType="pubmed">35843984</ArticleId><ArticleId IdType="pmc">9288923</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Cuadrado ML, G&#xf3;mez-Mayordomo V, Garc&#xed;a-Azor&#xed;n D, Arendt-Nielsen L (2023) Headache as a COVID-19 onset symptom or Post-COVID symptom according to the SARS-CoV-2 variant. Expert Rev Neurother 23:179&#x2013;186</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14737175.2023.2185138</ArticleId><ArticleId IdType="pubmed">36857191</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G et al (2021) Symptoms, complications and management of long COVID: a review. J R Soc Med 114:428&#x2013;442</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId><ArticleId IdType="pmc">8450986</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Dab&#xf3; L, Melgarejo-Mart&#xed;nez L, Caronna E, Pozo-Rosich P (2023) Headache in COVID-19 and Long COVID: to know facts for clinical practice. Curr Neurol Neurosci Rep 23:551&#x2013;560</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-023-01296-w</ArticleId><ArticleId IdType="pubmed">37665495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Sanchis-Gomar F, Henry BM (2023) COVID-19 and its long-term sequelae: what do we know in 2023? Pol Arch Intern Med 133:16402</Citation><ArticleIdList><ArticleId IdType="pubmed">36626183</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ (2022) Neurological sequelae of COVID-19. J Integr Neurosci 21:77</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng A, Shah M, Ahmad SA, Premraj L, Wildi K, Li Bassi G, Pardo CA, Choi A, Cho S-M (2023) Pathogenesis underlying neurological manifestations of long COVID syndrome and potential therapeutics. Cells 12:816</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12050816</ArticleId><ArticleId IdType="pubmed">36899952</ArticleId><ArticleId IdType="pmc">10001044</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Sarkar S, Fram TR et al Duration of post&#x2013;COVID-19 symptoms is associated with sustained SARS-CoV-2&#x2013;specific immune responses. JCI Insight 6:e151544</Citation></Reference><Reference><Citation>Tana C, Giamberardino MA, Martelletti P (2023) Long COVID and especially headache syndromes. Curr Opin Neurol 36:168</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000001153</ArticleId><ArticleId IdType="pubmed">37078648</ArticleId></ArticleIdList></Reference><Reference><Citation>Trigo J, Garc&#xed;a-Azor&#xed;n D, Sierra-Menc&#xed;a &#xc1;, Tamayo-Velasco &#xc1;, Mart&#xed;nez-Paz P, Tamayo E, Guerrero AL, Gonzalo-Benito H (2021) Cytokine and interleukin profile in patients with headache and COVID-19: a pilot, CASE-control, study on 104 patients. J Headache Pain 22:51</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-021-01268-w</ArticleId><ArticleId IdType="pubmed">34088273</ArticleId><ArticleId IdType="pmc">8177251</ArticleId></ArticleIdList></Reference><Reference><Citation>Adorjan K, Heindl B, Stubbe HC (2022) Post-COVIDLMU: Implementierung Und Evaluierung eines interdisziplin&#xe4;ren und sektoren&#xfc;bergreifenden versorgungs- und Forschungsnetzwerks f&#xfc;r eine evidenzgeleitete Behandlung Von Patienten Mit Schwerem Post-COVID-Syndrom. Nervenarzt 93:797&#x2013;803</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00115-022-01322-1</ArticleId><ArticleId IdType="pubmed">35695907</ArticleId><ArticleId IdType="pmc">9190193</ArticleId></ArticleIdList></Reference><Reference><Citation>Adorjan K, Ruzicka M, Ibarra G, Stubbe HC (2023) Behandlung Des Schweren Post-covid-syndroms. MMW Fortschr Med 165:52&#x2013;57</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15006-022-2187-y</ArticleId><ArticleId IdType="pubmed">36648675</ArticleId><ArticleId IdType="pmc">9844173</ArticleId></ArticleIdList></Reference><Reference><Citation>WHOQOL - Measuring Quality of Life| The World Health Organization https://www.who.int/tools/whoqol . Accessed 17 Jul 2023</Citation></Reference><Reference><Citation>WHOQOL-BREF| The World Health Organization https://www.who.int/tools/whoqol/whoqol-bref . Accessed 17 Jul 2023</Citation></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16:606&#x2013;613</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId><ArticleId IdType="pmc">1495268</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantini L, Pasquarella C, Odone A et al (2021) Screening for depression in primary care with Patient Health Questionnaire-9 (PHQ-9): a systematic review. J Affect Disord 279:473&#x2013;483</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.09.131</ArticleId><ArticleId IdType="pubmed">33126078</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado MO, Kang N-YC, Tai F, Sambhi RDS, Berk M, Carvalho AF, Chada LP, Merola JF, Piguet V, Alavi A (2021) Measuring fatigue: a meta-review. Int J Dermatol 60:1053&#x2013;1069</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijd.15341</ArticleId><ArticleId IdType="pubmed">33301180</ArticleId></ArticleIdList></Reference><Reference><Citation>Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121&#x2013;1123</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1989.00520460115022</ArticleId><ArticleId IdType="pubmed">2803071</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawthorne G, Herrman H, Murphy B (2006) Interpreting the WHOQOL-Br&#xe8;f: preliminary Population norms and effect sizes. Soc Indic Res 77:37&#x2013;59</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11205-005-5552-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Straube A, Aicher B, F&#xf6;rderreuther S, Eggert T, K&#xf6;ppel J, M&#xf6;ller S, Schneider R, Haag G (2013) Period prevalence of self-reported headache in the general population in Germany from 1995&#x2013;2005 and 2009: results from annual nationwide population-based cross-sectional surveys. J Headache Pain 14:11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1129-2377-14-11</ArticleId><ArticleId IdType="pubmed">23565641</ArticleId><ArticleId IdType="pmc">3620427</ArticleId></ArticleIdList></Reference><Reference><Citation>Straube A, Ruscheweyh R (2019) Epidemiologie Von Kopfschmerzen &#xfc;ber die Lebensspanne. Nervenheilkunde 38:735&#x2013;739</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-0988-4322</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke A, Neuhauser H (2009) Prevalence and burden of headache and migraine in Germany. Headache 49:79&#x2013;89</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1526-4610.2008.01263.x</ArticleId><ArticleId IdType="pubmed">19125877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipton RB, Pozo-Rosich P, Orr SL, Reed ML, Fanning KM, Dabruzzo B, Buse DC (2023) Impact of monthly headache days on migraine&#x2010;related quality of life: results from the chronic migraine epidemiology and outcomes (CaMEO) study. Headache 63:1448&#x2013;1457</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/head.14629</ArticleId><ArticleId IdType="pubmed">37795746</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E, Kusuma HI, Fahriani M, Harapan H, Syahrul S, Musadir N (2022) Headache in Post-COVID-19 patients: its characteristics and relationship with the quality of life. Med (Kaunas) 58:1500</Citation></Reference><Reference><Citation>Fujita K, Otsuka Y, Sunada N, Honda H, Tokumasu K, Nakano Y, Sakurada Y, Obika M, Hagiya H, Otsuka F (2023) Manifestation of Headache affecting Quality of Life in Long COVID patients. J Clin Med 12:3533</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12103533</ArticleId><ArticleId IdType="pubmed">37240639</ArticleId><ArticleId IdType="pmc">10219375</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rster C, Colombo MG, Wetzel A-J, Martus P, Joos S (2022) Persisting symptoms after COVID-19. Dtsch Arztebl Int 119:167&#x2013;174</Citation><ArticleIdList><ArticleId IdType="pubmed">35236547</ArticleId><ArticleId IdType="pmc">9215272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabacof L, Tosto-Mancuso J, Wood J et al (2022) Post-acute COVID-19 Syndrome negatively impacts physical function, cognitive function, Health-Related Quality of Life, and participation. Am J Phys Med Rehabil 101:48&#x2013;52</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PHM.0000000000001910</ArticleId><ArticleId IdType="pubmed">34686631</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis 53:737&#x2013;754</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId></ArticleIdList></Reference><Reference><Citation>Coughlin SS (1990) Recall bias in epidemiologic studies. J Clin Epidemiol 43:87&#x2013;91</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0895-4356(90)90060-3</ArticleId><ArticleId IdType="pubmed">2319285</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>